Clearside Biomedical is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space, or SCS. Co.'s SCS injection platform, utilizing its proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Co.'s SCS injection platform can be used in conjunction with existing drugs designed for delivery to the SCS, therapies and future therapeutic inventions. We show 33 historical shares outstanding datapoints in our coverage of CLSD's shares outstanding history.
Understanding the changing numbers of CLSD shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like CLSD versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching CLSD by allowing them to research CLSD shares outstanding history
as well as any other stock in our coverage universe. |
Free CLSD Email Alerts:
Video: Shares Outstanding Importance
